
Figure 1
The MPC project.
Table 1
Characteristics of the study population.
| PHASE 1 – STAKEHOLDERS | INTERVIEWS, N | 22 |
|---|---|---|
| Language, n Dutch French Function, n Policy maker Stakeholder External expert Mean duration, min | 13 9 8 10 4 60 | |
| PHASE 2 – SERVICE USERS | INTERVIEWS, N | 15* |
| Language, n Dutch French Function, n GP CP Mean duration, min | 6 9 5 11 55 | |
| OBSERVATIONS, N | 18 | |
| Language, n Dutch French Participants, n GP CP Other** Mean duration, min | 15 3 195 181 39 129 | |
| SURVEYS, N | 217 | |
| Language, n Dutch French Function, n GP CP Other** Age, median (IQR) | 169 48 102 99 16 41 (27) |
[i] * One Dutch interview was performed with one GP and one CP simultaneously.
** Others included nurses, intern pharmacists, medical specialists.

Figure 2
Results of perceived advantages of MPC, % (survey, n = 217).

Figure 3
Results of perceived interaction quality during the MPC meeting, % (survey, n = 217).

Figure 4
Intention to participate in future MPC meetings, % (survey, n = 217).
